Table 2.
Types of Vaccines
| Vaccine Type | Description | Immune Response Generated | Examples | Notes |
|---|---|---|---|---|
| Live attenuated | Weakened organism able to replicate in humans with reduced pathogenicity but retained immunogenicity | B and T call responses, induce immunological memory (memory B cells and long-lived plasma cells) | MMR, yellow fever, live attenuated influenza vaccine (LAIV), varicella | Contraindicated when CD4 < 200 or 15%. Avoid LAIV in PWH regardless of CD4 |
| Live nonreplicating | Weakened organism unable to replicate in humans | B and T cell responses, induce immunological memory | Modified Vaccinia Ankara (Jynneos) | Safe in PWH regardless of CD4 |
| Whole inactivated | Killed organism, unable to replicate or cause disease | B and T cell responses, induce immunological memory | Inactivated polio vaccine (IPV), HAV | May have higher reactogenicity |
| Subunit (multiple types) | ||||
| - Polysaccharide | Purified bacterial capsular polysaccharides from inactivated organism | T-cell independent, generate exclusively antibody-dependent response and do not induce immunological memory | PPSV23 | Limited immune memory |
| - Protein-polysaccharide conjugate | Purified polysaccharides from inactivated organism conjugated to a protein carrier | Engage T-cells and promote generation of memory B cells and long-lived plasma cells | PCV15/20/21, MenACWY | Common carrier proteins are tetanus toxoid, diphtheria toxoid (DT), CRM197 (non-toxic variant of DT) |
| - Purified protein | Purified protein from inactivated organism | B and T cell responses, induce immunological memory | Inactivated influenza vaccine | Often require adjuvants to enhance immune response |
| - Recombinant protein | Antigen produced through recombinant DNA technology | B and T cell responses, induce immunological memory | RZV (Shingrix), recombinant influenza vaccine (RIV), Heplisav-B | Often require adjuvants to enhance immune response |
| - Virus-like particle (VLP) | Recombinant capsid proteins that self-assemble as a shell to form VLPs | B and T cell responses, induce immunological memory | HPV, HBV (Engerix-B, Recom-bivax-HB) | Closely resemble viral structure, 9vHPV is highly immunogenic |
| - Outer membrane vesicle | Spherical buds made from the outer membrane of gram-negative bacteria that contain membrane surface proteins and lipids, vaccines typically also contain recombinant proteins | B and T cell responses, induce immunological memory | 4CMenB (Bexsero) | Strong immunogenicity due to bacterial membrane components |
| Toxoid | Inactivated toxins | B and T cell responses, induce immunologic memory | Diphtheria, tetanus | Neutralizes toxins rather than bacteria itself |
| mRNA | mRNA encoding antigen proteins encased in lipid nanoparticles | B and T cell responses, induce immunologic memory | SARS-CoV-2, RSV (mResvia) | Rapidly adaptable platform |
Adapted from Pollard AJ, Bijker EM, ‘A guide to vaccinology: from basic principles to new developments.’ Nat Rev Immunol. 2021;21(2):83–100[118]